BMC pulmonary medicine · 2026
Blood eosinophil count and clinical characteristics according to etiology in chronic obstructive pulmonary disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Seong Jeong Hyeon, Yoon Hee-Young, Lee Ye Jin, Joo Hyonsoo, Park Joo Hun, Lim Seong Yong, Lee Sang Yeub, Yoon Hyoung Kyu, Yoo Kwang Ha, Rhee Chin Kook
Аннотация
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition with multiple etiologies. We evaluated whether clinical characteristics differ according to COPD etiology.
METHODS: Patients with infection as the sole etiology were classified as the infection-related group (COPD-I, Group I), whereas those with any smoking-related etiology were assigned to the smoking-related group (COPD-C, Group C).
RESULTS: Of 873 patients included, 41 were classified as Group I and 832 as Group C. A significantly higher proportion of patients in Group I had a blood eosinophil count < 100 cells/µL compared to Group C (44.4% vs. 27.8%; p = 0.031). The inhaled corticosteroid (ICS) prescription rate was lower in Group I compared to Group C (25.7% vs. 41.5%; p = 0.063). Multivariable logistic regression confirmed that Group I was independently associated with a lower likelihood of ICS use (p = 0.018). In addition, Group I exhibited a significantly higher residual volume to total lung capacity ratio (48.88% vs. 43.28%; p = 0.030), indicating greater air trapping and small airway involvement.
CONCLUSIONS: These findings support the notion that infection-related COPD (COPD-I) represents a clinically distinct phenotype.
METHODS: Patients with infection as the sole etiology were classified as the infection-related group (COPD-I, Group I), whereas those with any smoking-related etiology were assigned to the smoking-related group (COPD-C, Group C).
RESULTS: Of 873 patients included, 41 were classified as Group I and 832 as Group C. A significantly higher proportion of patients in Group I had a blood eosinophil count < 100 cells/µL compared to Group C (44.4% vs. 27.8%; p = 0.031). The inhaled corticosteroid (ICS) prescription rate was lower in Group I compared to Group C (25.7% vs. 41.5%; p = 0.063). Multivariable logistic regression confirmed that Group I was independently associated with a lower likelihood of ICS use (p = 0.018). In addition, Group I exhibited a significantly higher residual volume to total lung capacity ratio (48.88% vs. 43.28%; p = 0.030), indicating greater air trapping and small airway involvement.
CONCLUSIONS: These findings support the notion that infection-related COPD (COPD-I) represents a clinically distinct phenotype.